» Eğitim Durumu

» Akademik Unvanlar

» İş Tecrübesi

» Yayınlar

SCI-SSCI veya SCI Expanded Kapsamındaki Yayınları

  • O. KÖSTEK, Y. BOZKAYA, B. M. HACIOGLU, N. Ö. YILDIRIM, E. YILMAZ, C. N. DEMIRCAN, B. ERDOGAN, S. UZUNOGLU, I. ÇIÇIN, N. ZENGIN, Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?, Archives of Iranian Medicine, vol. 22, no. 1, pp. 236-241, 5, 2019
  • O. KÖSTEK, B. M. HACIOGLU, A. SAKIN, T. DEMIR, M. SARI, Ö. ÖZKUL, M. ARAZ, F. A. DOGAN, C. N. DEMIRCAN, S. UZUNOGLU, I. ÇIÇIN, B. ERDOGAN, Regorafenib or rechallenge chemotherapy: Which is more effective in the third-line treatment of metastatic colorectal cancer?, CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 83, no. 1, pp. 115-122, 1, 2019
  • S. DEGIRMENCIOGLU, Ö. TANRIVERDI, S. MENEKSE, M. DOGAN, B. M. HACIOGLU, E. OKTAY, E. DILEK, E. ARPACI, B. U. OYAN, S. TURHAL, M. YILMAZ, K. PILANCI, A. SAKIN, M. ARAZ, S. ÇOKMERT, Ö. ÖZDEMIR, E. SEN, E. NAYIR, A retrospective analysis on first-line bevacizumab, cetuximab,and panitumumab-containing regimens in patients with RASwildmetastatic colorectal cancer: A Collaborative Study byTurkish Oncology Group (TOG), Journal of BUON, vol. 24, no. 1, pp. 242-248, 1, 2019
  • D. TURAL, M. KARACA, A. ZIRTILOGLU, B. M. HACIOGLU, N. A. M. SENDUR, A. ÖZET, Receptor discordances in locally advanced breast cancer afterneoadjuvant chemotherapy and their effects on survival, Journal of BUON, vol. 24, no. 1, pp. 20-25, 1, 2019
  • A. GÖKYER, A. KÜÇÜKARDA, O. KÖSTEK, B. M. HACIOGLU, S. B. SUNAL, C. N. DEMIRCAN, S. UZUNOGLU, S. SOLAK, K. ISSEVER, I. ÇIÇIN, B. ERDOGAN, Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib, Clinical and Translational Oncology, 3, 2019
  • O. KÖSTEK, E. YiLMAZ, B. M. HACIOGLU, C. N. DEMIRCAN, A. GÖKYER, S. UZUNOGLU, N. TUNÇBILEK, I. ÇIÇIN, B. ERDOGAN, Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer, Cancer Chemotherapy and Pharmacology, vol. 83, no. 4, pp. 735-742, 4, 2019
  • Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer? Köstek O, Hacıoğlu MB, Sakin A, Demir T, Sarı M, Ozkul O, Araz M, Doğan AF, Demircan NC, Uzunoğlu S, Çiçin İ, Erdoğan B. Cancer Chemother Pharmacol. 2018 Oct 29. doi: 10.1007/s00280-018-3713-6 (Kasım 2018)
  • Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma. Karatas F, Sahin S, Aytekin A, Hacioglu MB, Imamoglu GI, Altinbas M. J Cancer Res Ther. 2018 Jul-Sep;14(5):1149-1151. doi: 10.4103/0973-1482.188293. (Eylül 2018)
  • Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma. Kostek O, Yilmaz E, Bekir Hacıoglu M, Erdogan B, Kodaz H, Turkmen Bekmez E, Hacibekiroglu I, Uzunoglu S, Tuncbilek N, Cicin I. J BUON. 2018 Jul-Aug;23(4):979-984. (Eylül 2018)
  • Renal cellcarcinoma presenting with heart metastasis without inferior vena caval and right atrialinvolvement. Sahin S, Karatas F, Hacioglu MB, Aytekin A, Cilbir E, Conkbayir I. J Cancer Res Ther. 2018 Jan-Mar;14(2):457-458. (Mart 2018)
  • Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis. Muhammet Hacioglu B, Kostek O, Erdogan B, Uzunoglu S, Cicin I. J BUON. 2017 May-Jun;22(3):586-591. (Mayıs 2017)
  • Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer. Sahin S, Karatas F, Erdem GU, Hacioglu B, Altundag K. . Am Surg. 2017 Apr 1;83(4):359-364. (Nisan 2017)
  • K-RAS and N-RAS mutations in testicular germ cell tumors.Hacioglu BM, Kodaz H, Erdogan B, Cinkaya A, Tastekin E, Hacibekiroglu I, Turkmen E, Kostek O, Genc E, Uzunoglu S, Cicin I.Bosn J Basic Med Sci. 2017 Apr 20. doi: 10.17305/bjbms.2017. (Nisan 2017)
  • Comparison of survival with somatostatin analog and chemotherapy and Prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less. Özaslan E, Karaca H, Koca S, Sevinç A, Hacioğlu B, Özkan M, Özçelik M, Duran AO, Hacibekiroğlu İ, Yildiz Y, Tanriverdi Ö, Menekşe S, Aksoy A, Bozkurt O, Urvay S, Uysal M,Demir H, Çiltaş A, Dane F. Anticancer Drugs. 2017 Feb;28(2):222-229. (Şubat 2017)
  • Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas. İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi10, Yusuf Günaydin11, Serkan Menekşe12, Berna Öksüzoğlu, Asude Aksoy13, Bülent Erdogan, M Bekir Hacıoglu, Erkan Arpaci14, Alper Sevinç1.Balkan Med J 2016;33:517-24 (Eylül 2016)
  • Impact of active smokingon survival of patients with metastatic lung adenocarcinoma harboring an epidermal growthfactor receptor (EGFR) mutation. Erdogan B, Kodaz H, Karabulut S, Cinkaya A, Tozkir H, Tanriverdi O, Cabuk D,Hacioglu MB, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. Bosn J Basic MedSci. 2016 Jul 1.doi:10.17305/bjbms.2016.1380. (Temmuz 2016)
  • Effectiveness and safety ofcabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkishpatients (The Anatolian Society of Medical Oncology).Süner A, Aydın D, Hacıoğlu MB, Doğu GG, İmamoğlu GI, Menekşe S, Pilancı KN,Yazıcı ÖK, Koca D, Karaağaç M, Akyol M, Akman T, Ergen S, Avcı N, Kaçan T, Bozkurt O,Kefeli U, Urakçı Z, Araz M, Arpacı E, Harputlu H, Sevinç A. Eur Rev Med Pharmacol Sci. 2016Apr;20(7):1238-43. (Nisan 2016)
  • How long should we maintain anti-HER2 therapyf or metastatic breast cancer patients with complete remission? Hacioglu B, Akin S, Babacan T, Sever AR, Altundag K. Future Oncol. 2015;11(20):2799-801. (Kasım 2015)
  • A rare coexistence—Chronic lymphocytic leukemia and Kaposi sarcoma: Case report and review of the literature. Hacioglu MB, Sahin S, Karatas F, Aytekin A. J Cancer Res Ther. 2015 Oct-Dec;11(4):954-6. (Ekim 2015)
  • Krukenberg tumor presenting with amenorrhea as the sole initial symptom: Casereportandreview of theliterature. Sahin S, Karatas F, Hacioglu B, Aytekin A, Imamoglu I, Koseoglu N, Sari E, AltinbasM. J Cancer Res Ther. 2015 Oct-Dec;11(4):1024. (Ekim 2015)
  • Does eribulinMesylate cause recurrent transient diplopia? Karatas F, Hacioglu B, Akin S, Babacan T, Sever AR, Altundag K. J BUON. 2015 Sep-Oct;20(5):1379. (Eylül 2015)
  • Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients. Hacioglu B, Akin S, Sever AR, Altundag K. Future Oncol. 2015 Sep;11(18):2495-7. (Eylül 2015)
  • Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer and chronic renal failure- Second highest level of CA 19-9 in the literature. Aytekin A, Sahin S, Bekir Hacioglu M, Karatas F, Ince M. J BUON. 2015 Jul-Aug;20(4):1169-70. (Temmuz 2015)

Uluslararası Hakemli Dergilerde Yayınlanan Makaleler

  • O. KÖSTEK, B. M. HACIOGLU, Effect of Somatostatin Analogs on Prostate Volume, Medeniyet Medical Journal, vol. 34, no. 1, pp. 76-81, 6, 2019
  • Enzalutamide and Cancer. B Erdogan, O Kostek, M Bekir Hacioglu EJMO 2018;2(3):121–129 (Mart 2018)
  • Assessment of Prognostic Factors in Epithelial Ovarian Cancer. Yilmaz Onal, Osman Kostek, Muhammet Bekir Hacioglu, Bulent Erdogan, HilmiKodaz, Esma Turkmen Bekmez, Ilhan Hacibekiroglu, Sernaz Uzunoglu, Irfan Cicin. EJMO 2017;1(2):61–68 (Ekim 2017)
  • Clinical features of the patient with multiple primary tumors: Single center experience. Gokyer A, Kostek O, Hacioglu MB, Erdogan B, Kodaz H, Turkmen E, Hacibekiroglu I, Uzunoglu S, Cicin I. North Clin Istanb. 2017 May 10;4(1):43-51. (Mayıs 2017)
  • A Rare Cause of Acute Kidney Injury:Renal Arterial Thrombosis in a Small Cell Lung Cancer Patient. Osman Kostek, Muhammet Bekir Hacioglu, Seval Orman, Ceren Cetin, Nil Su Kodal, Bulent Erdogan, Sernaz Uzunoglu, Irfan Cicin.EJMO. 2017; 1(1): 41-43
  • Metastasis of Transitional Cell Carcinoma of the Bladder to the Orbit: A Case Report. Ahmed Cihad Genc, Muhammet Bekir Hacioglu, Osman Kostek, Ilhan Hacibekiroglu. EJMO 2017;1(1):47–48
  • Synchronous Renal CellCarcinoma and Primary Ocular Malignant Melanoma: Case Report. Aydin Aytekin, Suleyman Sahin, Rafiye Ciftciler, Hayriye Sahinli, Guldal Esendagli, Betül Cimer, Muhammet Bekir Hacioglu, Aydin Ciltas. EJMO. 2017; 1(1): 44-46
  • Combination of Docetaxel and Gemcitabine Ineffective in Metastatic Eccrine Porocarcinoma: A Case Report. Hilmi Kodaz, Muhammet Bekir Hacioglu, Osman Kostek, Bulent Erdogan, Ebru Tastekin, Cagnur Elpen Kodaz, Irfan Cicin. EJMO. 2017; 1(1): 38-40
  • Frequency of RAS Mutations (KRAS, NRAS, HRAS) in Human Solid Cancer-Review. Hilmi Kodaz, Osman Kostek, Muhammet Bekir Hacioglu, Bulent Erdogan, Cagnur Elpen Kodaz, Ilhan Hacibekiroglu, Esma Turkmen, Sernaz Uzunoglu, Irfan Cicin. EJMO2017;1(1):1–7
  • Durable response with medroxiprogesterone acetate in metastatic renalcell carcinoma: Case report, Hacioglu BM, Kostek O, Erdogan B, Kodaz H, Hacibekiroglu I, Turkmen E,Uzunoglu S, Cicin I. Journal of Oncological Science, 2016, 2(2-3), 69-70
  • Endometrial carcinoma and paraneoplastic immune thrombocytopenia. Kodaz H, Hacıoglu MB, Elpen Kodaz Ç, Cınkaya A, Erdogan B, Çıçın I. Journal of Oncological Science, 2016,2(1), 25-26
  • Isolated inguinal lymph node metastasis in early stage testicularseminoma: a case report and review of the literature. Aydin Aytekin, Suleyman Sahin, Muhammet Bekir Hacioglu, Fatih Karatas, NesrinGurcay, Mustafa Altinbas. EUR. J. ONCOL.; Vol. 21, n. 3, pp. 200-203, 2016
  • Diabetic and Nondiabetic Coronary Heart Disease with Patient Fibrinogen and Middle Platelet Volume for Atherosclerosis. MB Hacıoğlu, EG Altunoğlu, F Erdenen, E Ülgen, C Müderrisoğlu. , İstanbul Med J 2014; 15: 161-5
  • A Case of Constrictive Pericarditis with Ascites and Lower Extremities Varices, EG Altunoğlu, S Yurdakul, B Hacıoğlu, N Özbaş, Ç Alkoç, E Ülgen, İstanbul Med J 2013;14: 297-9
  • A patient withincomplete Behcet's disease presenting with portal vein thrombosis/Portal ven trombozu ile seyreden inkomplet Behcet hastaligi olan bir olgu sunumu. Esma Guldal Altunoglu, Bekir Hacioglu, Ender Ulgen, Feray Aktas, Cigdem Bulut, Sevinc Yardimci, Zeynep Kemik, Yurdaer Ozcan, Esen Karakas, Ismail Yildiz. Istanbul Medical Journal, vol. 13,no. 2, 2012, p. 101+
  • Renal Involvement İn The Laurence Moon Biedl Syndrome: A Case Report. Esma Güldal Altunoğlu, Ender Ülgen, Yurdaer Özcan, Hamza Aslanhan, Bekir Hacıoğlu. istanbul Tıp Derg - Istanbul Med J 2010;11(4):175-178

Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler (Proceedings)

  • Receptor discordance after neoadjuvant chemotherapyand its impact on disease-free survival. Deniz Tural, Mustafa Karaca, Bekir Hacioglu, Irem Bilgetekin, Burak Bilgin,Hakan Kocoglu, Gulsum Ozet, Bulent Erdogan, Mehmet Ali Nahit Sendur, Aydin Aytekin,Mustafa Benekli, Ahmet Ozet. 2016 American Society of Clinical OncologyAnnual Meeting, June 3-7, 2016; Chicago, Illinois
  • Efficacy and tolerability of first-linechemotherapy in elderly patients (age ≥70 years) with metastatic gastric cancer: a multicenterstudy of the Anatolian Society of Medical Oncology (ASMO). MN Aldemir, M Turkeli, B Hacioglu, A Sakin, E Yaman, E Coban, D Koca, MKaraca, M Simsek, A Bahceci, E Sen, T Eren, BÖ Aliustaoglu, T Sakalar, NO Kalkan, GAktas, M Bilici, S Turhal, M Benekli, SB Tekin. 2016 American Society ofClinical Oncology Annual Meeting, June 3-7, 2016; Chicago, Illinois
  • The significance of the serum leptin,ghrelin, tumor necrosis factor alpha and interleukine-1 levels in patients with non-small cell lung cancer. Fatih Karatas, Bulent Yalcin, Hakan Akbulut, Gungor Utkan, Suleyman Sahin, Ahmet Demirkazik, Bekir Hacioglu, Fikri Icli. 2015 American Society of Clinical Oncology Annual Meeting, May 29-June 2, 2015; Chicago, Illinois
  • A Rare Cause In The Etıology Of HepatocellularCancer: Clomıpramıne Hydrochlorıde. Fatih Karataş, Süleyman Şahin, Muhammet Bekir Hacıoğlu, Aydın Aytekin, EbruSarı, Tamer Selen, Mustafa Altınbaş. December 12 - 14, 2014 – İstanbul/ Turkey 4thInternational Gastrointestinal Cancers Conference- Ps-018 (Aralık 2014)
  • A Good 5 Year Survıval Rate After Multıple SurgıcalResectıon Of Multıple Metastases From Mucınous Adenocarcınoma Of Colon. Muhammet Bekir Hacıoğlu, Süleyman Şahin., Aydın Aytekin., Fatih Karataş, EbruSarı, Tamer Selen, Mustafa Altınbaş. December 12- 14, 2014 – İstanbul/ Turkey 4th International Gastrointestinal Cancers Conference-Ps-043 (Aralık 2014)
  • Synchronous Bladder And Prostate Cancer In APatıent Prevıously Dıagnosed Wıth Gastrıc Cancer: Trıple Multıple Prımary Tumors. Muhammet Bekir Hacıoğlu, Süleyman Şahin, Aydın Aytekin, Fatih Karataş,Tamer Selen, Ebru Sarı, Mustafa Altınbaş. December 12 - 14, 2014 – İstanbul/ Turkey 4th International Gastrointestinal Cancers Conference- Ps-019 (Aralık 2014)

Ulusal Hakemli Dergilerde Yayınlanan Makaleler

  • S. SAHIN, B. M. HACIOGLU, Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study, Istanbul Medical Journal, vol. 20, no. 2, pp. 82-87, 4, 2019

Yazılan Ulusal Kitaplar veya Kitaplarda Bölümler

  • B. M. HACIOĞLU, B. ERDOĞAN, İ. ÇİÇİN, GEBELİKTE SARKOM TEDAVİSİ, Ulusal, Bölüm: GEBELİK VE SARKOMLAR, Basım Türü: Basılı, pp. 195-207, TÜRKİYE-, ISBN978-975-277-675-3, GÜNEŞ TIP KİTAPEVİ, 20171. Basım (Ocak 2017)

Editörlük / Yayınlama

  • Eurasian Journal of Medical Investigation ( EJMI ), Ulusal, TÜRKİYE-, Kare Publishing,
  • Eurasian Journal of Medicine and Oncology (EJMO), Ulusal, TÜRKİYE-, Kare Publishing,

Diğer

  • B. M. HACIOGLU, I. ÇIÇIN, Immünoterapilerde Yan Etki Yönetimi, Ulusal, Bölüm: Immünoterapilerin Nadir Toksisiteleri ve Yönetimi, Basim Türü: Basili, pp. 120-144, TÜRKIYE-Ankara, ISBN978-605-7650-02-3, Türkiye Klinikleri, 20191. Basim
  • B. M. HACIOGLU, B. ERDOGAN, I. ÇIÇIN, GEBELIKTE KANSER TEDAVISI, Ulusal, Bölüm: GEBELIK VE SARKOMLAR, Basim Türü: Basili, pp. 195-205, TÜRKIYE-ANKARA, ISBN978-975-277-675-3, GÜNES TIP KITABEVI, 20191. Basim